A phase 1b/2 study to evaluate the safety and efficacy of TTI-101 as monotherapy and in combination in advanced hepatocellular carcinoma.

Authors :: Dayyani, Farshid
Baretti, Marina
Lee, Sunyoung S.
He, Aiwu Ruth
Kim, Richard D.
Lin, Bruce Shih-Li
Enzler, Thomas
Al Hallak, Mohammed Najeeb
Ulahannan, Susanna Varkey
Davis, S. Lindsey
Burgoyne, Adam
Tweardy, David
Harding, James J.
Kaseb, Ahmed Omar
de Achaval, Sofia
Alibhai, Imran
Kauh, John S.
Source :: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, pTPS577-TPS577, 151p
Publication Year :: 2024

Full Text Access

Tools